Physician profile
Donald E Crabtree
NPI 1760649388
$3,271.26
in general payments reported to CMS, 2019-2025
13 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,023 · 2020: $239 · 2021: $124 · 2022: $152 · 2023: $324 · 2024: $279 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,005.67 | 2019 | |
| Boston Scientific Corporation | $459.39 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $278.20 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Collegium Pharmaceutical, INC. | $150.71 | 2020-2023 | Xtampza |
| Phathom Pharmaceuticals, INC. | $124.80 | 2024 | Voquezna |
| Globus Medical, INC. | $59.72 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $40.70 | 2019-2021 | |
| Allergan, INC. | $40.44 | 2020-2021 | |
| Nevro Corp. | $38.17 | 2020-2023 | Senza |
| Redhill Biopharma INC. | $24.50 | 2021 | |
| Abbott Laboratories | $16.86 | 2024 | Proclaim |
| Arbor Pharmaceuticals, INC. | $16.57 | 2021 | |
| Zyla Life Sciences, INC. | $15.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Crabtree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.